Michael Kuligowski, based in United States, is currently a Vice President, Dermatology, Clinical Research Group at Thermo Fisher Scientific, bringing experience from previous roles at Incyte, Merz Pharmaceuticals - now operating as Merz North America, Inc., Stiefel, a GSK company and Pfizer. Michael Kuligowski holds a Doctor of Medicine - MD @ Medical University of Warsaw - MUW. With a robust skill set that includes Dermatology, Clinical Development, Clinical Research, Pharmaceutical Industry, Clinical Trials and more, Michael Kuligowski contributes valuable insights to the industry. Michael Kuligowski has 2 emails on RocketReach.